Danish pharmaceutical company Novo Nordisk A/S (NVO) reported Friday that its third-quarter net profit edged up 1 percent to 10.30 billion Danish kroner from last year's 10.19 billion kroner. Earnings per share/ADR grew 3 percent to 4.42 kroner from 4.29 kroner last year.
Operating profit decreased 1 percent from last year to 12.81 billion kroner. The gross margin was 83.3 percent, slightly higher than 83.2 percent last year.
For comments and feedback contact: editorial@rttnews.com
Business News
May 15, 2026 15:25 ET Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.